1	9 pregnancy female adult and adolescent who have attain menarche must have a negative pregnancy test at study entry and commit to use an acceptable method of barrier or hormonal contraception e.g. condom diaphragm oral contraceptive or long acting progestin agent if sexually active during the study and|oral contraceptive[214,232]||||||||||2821|2821|oral contraceptive
1	9 pregnancy female adult and adolescent who have attain menarche must have a negative pregnancy test at study entry and commit to use an acceptable method of barrier or hormonal contraception e.g. condom diaphragm oral contraceptive or long acting progestin agent if sexually active during the study and|progestin[248,257]||||||||||8725|8725|progestin
1	9 pregnancy female adult and adolescent who have attain menarche must have a negative pregnancy test at study entry and commit to use an acceptable method of barrier or hormonal contraception e.g. condom diaphragm oral contraceptive or long acting progestin agent if sexually active during the study and|long acting[236,247]||||||||||91461|91461|long acting
2	for 3 month after the last dose of valproic acid|valproic acid[339,352]|||||||3 month[308,315]||C0042291|11118|11118|valproic acid
